Journal of Pathology

Papers
(The TQCC of Journal of Pathology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors159
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment86
SMARCA4‐deficient rhabdoid tumours show intermediate molecular features between SMARCB1‐deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type80
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance77
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats76
Modelling hereditary diffuse gastric cancer initiation using transgenic mouse‐derived gastric organoids and single‐cell sequencing73
Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids67
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities63
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation59
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy54
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer52
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells51
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients50
Presence of Tim3+ and PD‐1+CD8+T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and di48
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma47
Issue Information46
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer46
Artificial intelligence to identify genetic alterations in conventional histopathology43
Escape from senescence: molecular basis and therapeutic ramifications41
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma40
Pseudobudding: ruptured glands do not represent true tumor buds39
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer39
In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and 38
CRISPR–Cas9 screening identifies the role of FER as a tumor suppressor38
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer37
Field cancerization in breast cancer37
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells37
Integrating computational pathology and proteomics to address tumor heterogeneity33
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response33
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT131
30
30
Downregulated BMP–Smad1/5/8 signaling causes emphysema via dysfunction of alveolar type II epithelial cells29
Primary thyroid B‐cell lymphoma: molecular insights into its clonal evolution and relapse29
Development of a multi‐scanner facility for data acquisition for digital pathology artificial intelligence29
On the origin of gastric tumours: analysis of a case with intramucosal gastric carcinoma and oxyntic gland adenoma29
Characterisation of an enhanced preclinical model of experimental MPO‐ANCA autoimmune vasculitis28
Integrative analysis of genomic and transcriptomic data of normal, tumour, and co‐occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour27
The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies27
Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma27
27
Minigene‐based splicing analysis and ACMG/AMP‐based tentative classification of 56 ATM variants27
Prediction of coexisting invasive carcinoma on ductal carcinoma in situ (DCIS) lesions by mass spectrometry imaging27
Issue Information27
Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration26
Adrenomedullin2 stimulates progression of thyroid cancer in mice and humans under nutrient excess conditions26
Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type25
Issue Information25
Copy‐number intratumor heterogeneity increases the risk of relapse in chemotherapy‐naive stage II colon cancer25
25
24
Somatic loss ofATMis a late event in pancreatic tumorigenesis24
Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72‐ALS24
24
Tumor immune microenvironment alterations associated with progression in human intraductal papillary mucinous neoplasms23
Lineage tracing in human tissues23
23
PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma23
BMP signalling in colorectal cancer: losing the yin to WNTs yang23
Deep learning based on hematoxylin–eosin staining outperforms immunohistochemistry in predicting molecular subtypes of gastric adenocarcinoma22
PCDHGC3 hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas22
Integrated molecular characterization of esophageal basaloid squamous cell carcinoma: a subtype with distinct RNA expression pattern and immune characteristics, but no specific genetic muta22
The earliest events in BRAF‐mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct p21
Issue Information21
Long‐term treatment of cancer‐prone germline PTEN mutant mice with low‐dose rapamycin extends lifespan and delays tumour development21
Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer21
21
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer21
Issue Information21
Organoids in cancer research: a review for pathologist‐scientists21
Liver insulin‐like growth factor‐1 mediates effects of low‐intensity vibration on wound healing in diabetic mice20
C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter‐mediated doxorubicin resistance20
Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1‐mutant soft‐tissue sarcoma of childhood20
DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental lineage in rhabdomyosarcoma tumours forming in genetically engineered20
Cell division‐dependent dissemination following E‐cadherin loss underlies initiation of diffuse‐type gastric cancer20
Assessing spatial sequencing and imaging approaches to capture the molecular and pathological heterogeneity of archived cancer tissues20
Multiregion exome sequencing indicates a monoclonal origin of esophageal spindle‐cell squamous cell carcinoma19
19
Issue Information19
19
Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy19
Caspase activation in tumour‐infiltrating lymphocytes is associated with lymph node metastasis in oral squamous cell carcinoma19
Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes18
Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney18
Re‐interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation18
SOX9 has distinct roles in the formation and progression of different non‐small cell lung cancer histotypes18
Human colonic organoids for understanding early events of familial adenomatous polyposis pathogenesis17
Defining the first bona fide cell model for SMARCA4‐deficient, undifferentiated tumor17
Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy17
Divergent evolution of metachronous follicular lymphoma and extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue from a common precursor17
Differential involvement of LUBAC‐mediated linear ubiquitination in intestinal epithelial cells and macrophages during intestinal inflammation17
Pancancer cytotoxic T‐cell trapping: are neutrophil extracellular traps a viable biomarker for immunotherapy response?17
Spasmolytic polypeptide‐expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer16
Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features16
Histone deacetylase 6 inhibition attenuates pathological cardiac hypertrophy by promoting autophagy through MAP1LC3B ubiquitination16
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis16
Anti‐CD40L therapy prevents the formation of precursor lesions to gastric B‐cell MALT lymphoma in a mouse model16
Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions16
Consensus molecular subtype transition during progression of colorectal cancer15
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens15
Unleashing the potential of AI for pathology: challenges and recommendations15
Jeremy Jass Prize for Research Excellence in Pathology 202115
Issue Information15
The spectrum and significance of secondary (co‐occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis15
Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage15
Evidence for etiologic field changes in tongue distant from tumor in patients with squamous cell carcinoma of the oral tongue15
UPK3A+ umbrella cell damage mediated by TLR3–NR2F6 triggers programmed destruction of urothelium in Hunner‐type interstitial cystitis/painful bladder syndrome15
The state of the art for artificial intelligence in lung digital pathology15
‘Experimentally‐induced anti‐myeloperoxidase vasculitis does not require properdin, MASP‐2 or bone marrow‐derived C514
Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid14
Integrative analysis of transcriptomic and metabolomic profiles reveals abnormal phosphatidylinositol metabolism in follicles from endometriosis‐associated infertility patients14
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis14
Local factor H production by human choroidal endothelial cells mitigates complement deposition: implications for macular degeneration14
Indoleamine 2,3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐1914
Clinical significance of pancreatic ductal metaplasia14
Application of digital pathology‐based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response14
Issue Information14
Issue Information14
Immune‐related gene expression signatures: a step forward in the stratification of patients with ovarian clear cell carcinoma14
PI3 expression predicts recurrence after chemotherapy with DNA‐damaging drugs in gastric cancer14
Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors14
RAF1MEK/ERK pathway‐dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation14
Brg1 is required to maintain colorectal cancer stem cells13
Clonal dynamics of chronic myelomonocytic leukemia progression: paired‐sample comparison13
Extracellular vesicles arising from apoptosis: forms, functions, and applications13
Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma13
13
CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder13
Abstracts13
Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11‐deficient mice13
Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects13
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response13
13
Issue Information13
Tumor‐infiltrating lymphocytes‐based subtypes and genomic characteristics of EBV‐associated lymphoepithelioma‐like carcinoma13
Contribution of alterations in peritubular capillary density and microcirculation to the progression of tubular injury and kidney fibrosis13
Fibrinogen Aα‐chain amyloidosis outbreaks in Japanese squirrels (Sciurus lis): a potential disease model13
Computer‐extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors13
Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition13
Oronasal mucosal melanoma is defined by two transcriptional subtypes in humans and dogs with implications for diagnosis and therapy12
Molecular genetic evidence supporting diverse histogenic origins of germ cell tumors12
FOXL2C134W: much ado about something!12
FOXL2 in adult‐type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?12
Issue Information12
12
Disseminated cancer cells detected by immunocytology in lymph nodes of NSCLC patients are highly prognostic and undergo parallel molecular evolution12
NEIL3 promotes hepatoma epithelial–mesenchymal transition by activating the BRAF/MEK/ERK/TWIST signaling pathway12
Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer‐rich regions and 38 spliceogenic variants12
Issue Information12
Role of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury12
Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport mice12
Downregulation of HDAC9 by the ketone metabolite β‐hydroxybutyrate suppresses vascular calcification11
Disorganisation of basement membrane zone architecture impairs melanocyte residence in vitiligo11
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value i11
A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer11
Ferrostatin‐1 modulates dysregulated kidney lipids in acute kidney injury11
The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma11
10
Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involveme10
Issue Information10
Issue Information10
Reducing the risks of nuclear war – the role of health professionals10
Cancer‐associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2IGF1R and Hippo–YAP1 signaling pathways10
10
Peak density of immature nerve cells occurs with high‐grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas10
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer10
0.08948802947998